Polycystin-L2 Activators
Polycystin-L2 activators exert their influence through a variety of biochemical mechanisms, primarily centered on modulating intracellular signaling cascades that Polycystin-L2 is a part of. Certain activators work by increasing levels of cyclic AMP (cAMP) within cells. This is achieved through the activation of adenylyl cyclase or inhibition of phosphodiesterases, leading to the accumulation of cAMP, which then activates protein kinase A (PKA). PKA, in turn, may phosphorylate Polycystin-L2, thereby increasing its activity. Other activators mimic the action of cAMP, directly engaging PKA and bypassing the need for upstream stimulation. This engagement with PKA signaling mechanisms ensures that Polycystin-L2 is more likely to be in a functionally active state.
Furthermore, the regulation of intracellular calcium plays a critical role in modulating the activity of Polycystin-L2. Several activators achieve this by either directly influencing calcium influx through ion channels or by modulating the receptors that control calcium signaling, such as cannabinoid and nicotinic acetylcholine receptors. Alterations in calcium levels can lead to the activation of calcium-sensitive pathways that Polycystin-L2 is involved in. Additionally, some activators affect tyrosine kinase signaling, which could have downstream effects on Polycystin-L2 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
Inhibitor of phosphodiesterases, which prevents cAMP degradation, potentially increasing Polycystin-L2 activity due to the protein's involvement in cAMP-mediated signaling cascades. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
β-adrenergic agonist that can induce cAMP production, which, in turn, could lead to the activation of Polycystin-L2 through cAMP-dependent pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC) which may phosphorylate Polycystin-L2 directly or modulate its activity through downstream effects on cell signaling. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
A cAMP analog resistant to hydrolysis by phosphodiesterases that can activate PKA and subsequently increase Polycystin-L2 activity through phosphorylation. | ||||||
1α,25-Dihydroxyvitamin D3 | 32222-06-3 | sc-202877B sc-202877A sc-202877C sc-202877D sc-202877 | 50 µg 1 mg 5 mg 10 mg 100 µg | $220.00 $645.00 $1000.00 $1500.00 $440.00 | 32 | |
Modulates intracellular calcium levels through its actions on calcium transport proteins, which could indirectly activate Polycystin-L2, as it is involved in calcium signaling pathways. | ||||||
Capsaicin | 404-86-4 | sc-3577 sc-3577C sc-3577D sc-3577A | 50 mg 250 mg 500 mg 1 g | $96.00 $160.00 $240.00 $405.00 | 26 | |
Activates transient receptor potential vanilloid 1 (TRPV1) channels, influencing calcium influx and possibly activating Polycystin-L2, given its role in calcium-mediated signaling. | ||||||
ADP | 58-64-0 | sc-507362 | 5 g | $54.00 | ||
Serves as a ligand for purinergic receptors which regulate intracellular calcium levels, potentially activating Polycystin-L2 via calcium signaling pathways. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Inhibits tyrosine kinases and may influence downstream signaling pathways that involve Polycystin-L2, potentially leading to its activation through non-receptor tyrosine kinase signaling. | ||||||